Preventive or therapeutic agent for renal disease
CA 2479254 A1 · Owner: Kissei Pharmaceutical Co. Ltd. · Inventors: Koizumi, Takashi; Hoyano, Yuji; Akahane, Satoshi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A novel medicinal composition which contains as an active ingredient either a compound represented by the general formula I (wherein R1 is hydrogen or optionally substituted alkyl; R2 is dialkylamino alkyl, cycloalkyl, optionally substituted aryl etc.; T is oxygen, sulfur, etc.; Q is hydrogen or optionally substituted alkyl; and Z is hydrogen hydroxy, etc.) or a , pharmacologically acceptable salt of the compound. The medicinal composition is highly effective in inhibiting mesangial cell proliferation and lowering urinary protein and is useful for the prevention of or treatments for various kidney diseases such as IgA nephropathy diabetic nephropathy, and nephrotic , syndrome.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 18, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 18, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 18, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.